This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo

More Than Words: Reflections of a General Counsel

Abstract

As we approach the second decade of the 21st century, general counsel have a unique opportunity to pause and reflect. We began the previous decade with a stock market crash and ended it with the greatest global economic crisis since the 1930’s. In between, we have seen many companies collapse under the weight of massive internal fraud and corruption. We saw the Sarbanes-Oxley Act and other legislation enacted as a reaction to a series of corporate and accounting scandals including those affecting Enron, Parmalat, Shell, Tyco, WorldCom and others. The U.S. Department of Justice continues to expand the scope of the Foreign Corrupt Practices Act, setting the pace for unprecedented growth in U.S. and international enforcement of anti-corruption laws. The record $1.3 billion in fines paid by Siemens to settle bribery allegations serves as a compelling example of the catastrophic financial loss that is a consequence of an integrity lapse or worse, the absence of a culture driven by high performance with unyielding integrity. Globalization has added various other challenges to the role of GCs, including navigating a materially changing landscape of legal, regulatory and reputational risk.

Read Paper

Company

Mars

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

Related Papers

Managing Compliance Risk in a COVID and Post-COVID World
Managing risk can be complicated in the best of times, and the challenges associated with risk management become even greater when combined with the tremendous disruption caused by a global...Read more
Portrait image of Brenda Crabtree
Brenda Crabtree
Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Tatiyana Akers
Tatiyana Akers
Associate Director, Compliance, Aimmune Therapeutics, USA
Paper Title International Pharma Congresses during Covid-19
Pharmaceutical congresses and conferences are one of the preferred resources for doctors to learn about new research, treatments and indications . Such congresses in 2020 have become ‘virtual’ in response...Read more
Portrait image of Geraldine Benjamin
Geraldine Benjamin
English Solicitor, Bailhache Labesse Trustees, UK
Making it Stick: How to Provide Legal Advice that Influences Business Decisions
As attorneys, determining the most risk-averse legal advice to give to our business partners often comes naturally. After all, we have both academic and professional experience in considering legal questions. But...Read more
Portrait image of Joshua Axelrod
Joshua Axelrod
Brand Counsel, Celgene Corporation, USA
Client Centricity & the In-House Lawyer
The practice of law has evolved, particularly given the advent of significant technological advances, enhancements, and the evolving nature of the business world. Twenty years ago, first year law students’...Read more
Portrait image of Kari Loeser
Kari Loeser
Senior Counsel, Jazz Pharmaceuticals , USA